Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children

被引:2
|
作者
Amarillo, Maria Eugenia [1 ]
Moyano, Agustina [1 ]
Gerpe, Natalia Ferressini [1 ]
De Matteo, Elena [2 ]
Preciado, Maria Victoria [1 ]
Chabay, Paola [1 ]
机构
[1] Ricardo Gutierrez Children′s Hosp, Multidisciplinary Inst Invest Pediat Pathol IMIPP, Pathol Div,CONICET GCBA, Mol Biol Lab, Gallo,C1425EFD 1330, Buenos Aires, Argentina
[2] Ricardo Gutierrez Children′s Hosp, Pathol Div, C1425EFD, Buenos Aires, Argentina
关键词
EPSTEIN-BARR-VIRUS; CLASSICAL HODGKIN LYMPHOMA; SUSCEPTIBILITY; SURVIVAL;
D O I
10.1038/s41598-024-52666-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CD4 T cells play a key role in Epstein Barr virus (EBV) infection, by modulating latent antigen expression, and exhibiting cytotoxic and regulatory properties. Our aim was to evaluate the presence of Granzyme B (GZMB) and Foxp3 CD4 T cells at different EBV infection status and latency profiles. We examined CD4, GZMB, Foxp3, IL10, TGF-beta, CD4-GZMB and CD4-Foxp3 expression at the tonsils of pediatric patients with different infective status and EBV latency profiles. CD4+, GZMB+, Foxp3+, CD4-GZMB+ and CD4-Foxp3+ cell counts were higher at the interfollicular region. Higher expression of CD4-GZMB was found in primary infected patients compared to healthy carriers. In patients that expressed latency III antigens, we demonstrated lower CD4+, CD4-GZMB+, CD4-Foxp3+ expression; a negative correlation between the immunoregulatory cytokine IL-10+ and GZMB+ as well as a positive correlation of IL-10+ and CD4+. In patients expressing the lytic protein BMRF1, a positive correlation of TGF-beta+ with CD4-GZMB+ and CD4-Foxp3+ was observed. Our findings indicate that CD4-GZMB+ cells are involved in the restriction of primary EBV infection in pediatric patients, which could partially explain the lack of symptoms, whereas both CD4-GZMB+ and CD4-Foxp3+ cells could be involved in the modulation of latency.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Tonsillar cytotoxic CD4 T cells are involved in the control of EBV primary infection in children
    María Eugenia Amarillo
    Agustina Moyano
    Natalia Ferressini Gerpe
    Elena De Matteo
    Maria Victoria Preciado
    Paola Chabay
    Scientific Reports, 14
  • [2] The Era of Cytotoxic CD4 T Cells
    Cenerenti, Mara
    Saillard, Margaux
    Romero, Pedro
    Jandus, Camilla
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases
    Ruiz-Pablos, Manuel
    PATHOGENS, 2022, 11 (08):
  • [4] Tonsillar CD4+FOXP3+ T-regulatory cell dynamics in primary EBV infection
    Yen-Hung Chow
    Hsuen-Wen Chang
    Raymond Sia
    Pele Chong
    Charles Sia
    Immunologic Research, 2011, 50 : 97 - 101
  • [5] Tonsillar CD4+FOXP3+ T-regulatory cell dynamics in primary EBV infection
    Chow, Yen-Hung
    Chang, Hsuen-Wen
    Sia, Raymond
    Chong, Pele
    Sia, Charles
    IMMUNOLOGIC RESEARCH, 2011, 50 (01) : 97 - 101
  • [6] Cytotoxic CD4 T Cells in Antiviral Immunity
    Marshall, Nikki B.
    Swain, Susan L.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [7] Cytotoxic CD4 T cells in the mucosa and in cancer
    Venkatesh, Hrishi
    Tracy, Sean I.
    Farrar, Michael A.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue virus infection
    Tian, Yuan
    Sette, Alessandro
    Weiskopf, Daniela
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [9] Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells
    Meckiff, Benjamin J.
    Ladell, Kristin
    McLaren, James E.
    Ryan, Gordon B.
    Leese, Alison M.
    James, Eddie A.
    Price, David A.
    Long, Heather M.
    JOURNAL OF IMMUNOLOGY, 2019, 203 (05): : 1276 - 1287
  • [10] Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection?
    Juno, Jennifer A.
    van Bockel, David
    Kent, Stephen J.
    Kelleher, Anthony D.
    Zaunders, John J.
    Munier, C. Mee Ling
    FRONTIERS IN IMMUNOLOGY, 2017, 8